Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Page 13

M&A

Talking M&A: Trends in Healthtech and Biotech M&A

By Deal Contributors
|
Published: February 7th, 2023
Baker McKenzie partner Aarthi Belani, AbbVie head of immunology business development and acquisitions Rachel Strick, Flare Capital Partners co-founder Michael Greeley and Patient Square Capital founding partner Neel Varshney share their insights on M&A trends in the sectors for the third episode of the Talking M&A podcast.
Activism

Activist Investing Today: Saur on Peltz, Disney, Icahn, M&A

By Ronald Orol
|
Published: December 8th, 2022
Matt Saur, one of the founding partners of law firm Woolery, explains why Nelson Peltz faces an uphill battle at Disney, what it was like working with Carl Icahn on his Xerox campaign and why activists will continue to push for M&A.